| Dr John Warren Griffin, | |
|
540 Hemlock St, Macon, GA 31201-3202 | |
| (478) 743-8953 | |
| Not Available |
| Full Name | Dr John Warren Griffin |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Experience | 31 Years |
| Location | 540 Hemlock St, Macon, Georgia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346282415 | NPI | - | NPPES |
| 4330089-001 | Other | GA | CIGNA |
| 00791601A | Medicaid | GA | |
| 727532 | Other | GA | B/C B/S |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | 045482 (Georgia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Medical Center, Navicent Health (the) | Macon, GA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| The Ent Center Of Central Georgia, Pc | 6103817556 | 13 |
News Archive
Researchers at UT Southwestern Medical Center have identified neural pathways that increase understanding of how the brain regulates body weight, energy expenditure, and blood glucose levels - a discovery that can lead to new therapies for treating Type 2 diabetes and obesity.
ImmunoGen, Inc., a biotechnology company that develops targeted antibody-based anticancer products using its antibody expertise and Targeted Antibody Payload technology, today disclosed the profile and first preclinical data for the Company's novel IMGN529 product candidate for the treatment of B-cell malignancies including non-Hodgkin's lymphoma and chronic lymphocytic leukemia.
A newly published study from the University of Waterloo shows that when activity in a specific part of the brain is suppressed, our desire for high-calorie foods increases.
Magstim is the pioneer of TMS technology, having built a reputation for developing leading medical devices in the research field for over 25 years. ..
› Verified 6 days ago
| Entity Name | The Ent Center Of Central Georgia, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962449363 PECOS PAC ID: 6103817556 Enrollment ID: O20040524000395 |
News Archive
Researchers at UT Southwestern Medical Center have identified neural pathways that increase understanding of how the brain regulates body weight, energy expenditure, and blood glucose levels - a discovery that can lead to new therapies for treating Type 2 diabetes and obesity.
ImmunoGen, Inc., a biotechnology company that develops targeted antibody-based anticancer products using its antibody expertise and Targeted Antibody Payload technology, today disclosed the profile and first preclinical data for the Company's novel IMGN529 product candidate for the treatment of B-cell malignancies including non-Hodgkin's lymphoma and chronic lymphocytic leukemia.
A newly published study from the University of Waterloo shows that when activity in a specific part of the brain is suppressed, our desire for high-calorie foods increases.
Magstim is the pioneer of TMS technology, having built a reputation for developing leading medical devices in the research field for over 25 years. ..
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr John Warren Griffin, 540 Hemlock St, Macon, GA 31201-3202 Ph: (478) 743-8953 | Dr John Warren Griffin, 540 Hemlock St, Macon, GA 31201-3202 Ph: (478) 743-8953 |
News Archive
Researchers at UT Southwestern Medical Center have identified neural pathways that increase understanding of how the brain regulates body weight, energy expenditure, and blood glucose levels - a discovery that can lead to new therapies for treating Type 2 diabetes and obesity.
ImmunoGen, Inc., a biotechnology company that develops targeted antibody-based anticancer products using its antibody expertise and Targeted Antibody Payload technology, today disclosed the profile and first preclinical data for the Company's novel IMGN529 product candidate for the treatment of B-cell malignancies including non-Hodgkin's lymphoma and chronic lymphocytic leukemia.
A newly published study from the University of Waterloo shows that when activity in a specific part of the brain is suppressed, our desire for high-calorie foods increases.
Magstim is the pioneer of TMS technology, having built a reputation for developing leading medical devices in the research field for over 25 years. ..
› Verified 6 days ago
Dr. Andrew Tice, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 1136 Jackson Springs Rd, Macon, GA 31211 Phone: 478-746-9797 | |
Dr. Thomas William Holmes, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 540 Hemlock St, Macon, GA 31201 Phone: 478-743-8953 Fax: 478-743-1963 | |
Dr. Keith D. Holmes, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 540 Hemlock St, Macon, GA 31201 Phone: 478-743-8953 Fax: 478-743-1963 | |
Alejandro J. Correa, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 540 Hemlock St, Macon, GA 31201 Phone: 478-743-8953 Fax: 478-743-1963 | |
Dr. C. Warren Dunn, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 540 Hemlock St, Macon, GA 31201 Phone: 478-743-8953 Fax: 478-743-1963 | |
Dr. John Robert Newman, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 540 Hemlock St, Macon, GA 31201 Phone: 478-743-8953 Fax: 478-741-9556 |